Prevalence of body iron excess in the metabolic syndrome

被引：144
作者：
Bozzini, C
Girelli, D
Olivieri, O
Martinelli, N
Bassi, A
De Matteis, G
Tenuti, I
Lotto, V
Friso, S
Pizzolo, F
Corrocher, R
机构：
[1] Univ Verona, Dept Clin & Expt Med, I-37134 Verona, Italy
[2] Univ Verona, Inst Clin Chem, I-37100 Verona, Italy
来源：
DIABETES CARE | 2005年 / 28卷 / 08期
关键词：
D O I：
10.2337/diacare.28.8.2061
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2061 / 2063
页数：3
相关论文
共 30 条
  • [1] EASL International Consensus Conference on Haemochromatosis - Part II. Expert document
    Adams, P
    Brissot, P
    Powell, L
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 487 - 496
  • [2] Bozzini C, 2002, CLIN CHEM, V48, P622
  • [3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [4] Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models
    den Boer, M
    Voshol, PJ
    Kuipers, F
    Havekes, LM
    Romijn, JA
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) : 644 - 649
  • [5] Serum ferritin as a component of the insulin resistance syndrome
    Fernández-Real, JM
    Ricart-Engel, W
    Arroyo, E
    Balançá, R
    Casamitjana-Abella, R
    Cabrero, D
    Fernández-Castañer, M
    Soler, J
    [J]. DIABETES CARE, 1998, 21 (01) : 62 - 68
  • [6] Cross-talk between iron metabolism and diabetes
    Fernández-Real, JM
    López-Bermejo, A
    Ricart, W
    [J]. DIABETES, 2002, 51 (08) : 2348 - 2354
  • [7] Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study
    Festa, A
    D'Agostino, R
    Tracy, RP
    Haffner, SM
    [J]. DIABETES, 2002, 51 (04) : 1131 - 1137
  • [8] Non-invasive assessment of hepatic iron stores by MRI
    Gandon, Y
    Olivié, D
    Guyader, D
    Aubé, C
    Oberti, F
    Sebille, V
    Deugnier, Y
    [J]. LANCET, 2004, 363 (9406) : 357 - 362
  • [9] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
    Ganz, T
    [J]. BLOOD, 2003, 102 (03) : 783 - 788
  • [10] Venesection therapy of insulin resistance-associated hepatic iron overload
    Guillygomarc'h, A
    Mendler, MH
    Moirand, R
    Lainé, F
    Quentin, V
    David, V
    Brissot, P
    Deugnier, Y
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (03) : 344 - 349
123